PD Therapeutics 2009: Agenda & Speakers
The Michael J. Fox Foundation for Parkinson’s Research & The New York Academy of Sciences
Parkinson’s Disease Therapeutics Conference
New York, NY
September 30, 2009
|
Sept 30, 2009 |
|
|
8.00 |
Breakfast |
|
8.30 – 8.45 |
Welcome by J. William Langston, MD |
|
8.45 – 10.30 |
Novel Therapeutic Targets Mathias Baehr, MD, University Hospital Göttingen P. Jeffrey Conn, PhD, Vanderbilt University David Bumcrot, PhD, Alnylam Pharmaceuticals, Inc. |
|
10.30 – 11.00 |
Networking Break/Poster Viewing |
|
11:00 – 12.00 |
Novel Therapeutic Targets (cont’d) David Standaert, MD, PhD, University of Alabama at Birmingham Gretchen L. Snyder, PhD, Intra-Cellular Therapies, Inc. |
|
12.00 – 1.15 |
Lunch/Poster Viewing |
|
1.15 – 3.15 |
Research Tools and Resources Krystof Bankiewicz, MD, PhD, University of California, San Francisco Susan Bressman, MD, Beth Israel Medical Center Robert L. Nussbaum, MD, University of California, San Francisco Michael G. Schlossmacher, MD, University of Ottawa |
|
3.15 – 3.45 |
Networking Break/Poster Viewing |
|
3.45 – 4.45 |
Hot Topics in PD Franz Hefti, PhD, Avid Radiopharmaceuticals, Inc. Andrew Singleton, PhD, National Institute on Aging/NIH |
|
4.45 – 5.00 |
Closing Remarks |
|
5.00 – 7.00 |
Cocktail Reception/Poster Viewing |
